139 related articles for article (PubMed ID: 27538123)
1. Synthesis and Biological Evaluation of N-[2-(4-Hydroxyphenylamino)-pyridin-3-yl]-4-methoxy-benzenesulfonamide (ABT-751) Tricyclic Analogues as Antimitotic and Antivascular Agents with Potent in Vivo Antitumor Activity.
Segaoula Z; Leclercq J; Verones V; Flouquet N; Lecoeur M; Ach L; Renault N; Barczyk A; Melnyk P; Berthelot P; Thuru X; Lebegue N
J Med Chem; 2016 Sep; 59(18):8422-40. PubMed ID: 27538123
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of diarylthiazole derivatives as antimitotic and antivascular agents with potent antitumor activity.
Wang F; Yang Z; Liu Y; Ma L; Wu Y; He L; Shao M; Yu K; Wu W; Pu Y; Nie C; Chen L
Bioorg Med Chem; 2015 Jul; 23(13):3337-50. PubMed ID: 25937236
[TBL] [Abstract][Full Text] [Related]
3. Novel benzopyridothiadiazepines as potential active antitumor agents.
Lebegue N; Gallet S; Flouquet N; Carato P; Pfeiffer B; Renard P; Léonce S; Pierré A; Chavatte P; Berthelot P
J Med Chem; 2005 Nov; 48(23):7363-73. PubMed ID: 16279796
[TBL] [Abstract][Full Text] [Related]
4. Discovery of novel 2-N-aryl-substituted benzenesulfonamidoacetamides: orally bioavailable tubulin polymerization inhibitors with marked antitumor activities.
Liu Z; Zhou Z; Tian W; Fan X; Xue D; Yu L; Yu Q; Long YQ
ChemMedChem; 2012 Apr; 7(4):680-93. PubMed ID: 22311585
[TBL] [Abstract][Full Text] [Related]
5. Benzopyridooxathiazepine derivatives as novel potent antimitotic agents.
Gallet S; Flouquet N; Carato P; Pfeiffer B; Renard P; Léonce S; Pierré A; Berthelot P; Lebegue N
Bioorg Med Chem; 2009 Feb; 17(3):1132-8. PubMed ID: 19162484
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of 1-benzyl-N-(2-(phenylamino)pyridin-3-yl)-1H-1,2,3-triazole-4-carboxamides as antimitotic agents.
Prasad B; Lakshma Nayak V; Srikanth PS; Baig MF; Subba Reddy NV; Babu KS; Kamal A
Bioorg Chem; 2019 Mar; 83():535-548. PubMed ID: 30472555
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of 2- and 3-aminobenzo[b]thiophene derivatives as antimitotic agents and inhibitors of tubulin polymerization.
Romagnoli R; Baraldi PG; Carrion MD; Lopez Cara C; Preti D; Fruttarolo F; Pavani MG; Tabrizi MA; Tolomeo M; Grimaudo S; Di Cristina A; Balzarini J; Hadfield JA; Brancale A; Hamel E
J Med Chem; 2007 May; 50(9):2273-7. PubMed ID: 17419607
[TBL] [Abstract][Full Text] [Related]
8. Antimitotic and antivascular activity of heteroaroyl-2-hydroxy-3,4,5-trimethoxybenzenes.
Lee HY; Chang CY; Lai MJ; Chuang HY; Kuo CC; Chang CY; Chang JY; Liou JP
Bioorg Med Chem; 2015 Aug; 23(15):4230-4236. PubMed ID: 26160020
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, antimitotic and antivascular activity of 1-(3',4',5'-trimethoxybenzoyl)-3-arylamino-5-amino-1,2,4-triazoles.
Romagnoli R; Baraldi PG; Salvador MK; Prencipe F; Bertolasi V; Cancellieri M; Brancale A; Hamel E; Castagliuolo I; Consolaro F; Porcù E; Basso G; Viola G
J Med Chem; 2014 Aug; 57(15):6795-808. PubMed ID: 25025853
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, anti-cancer evaluation of benzenesulfonamide derivatives as potent tubulin-targeting agents.
Yang J; Yang S; Zhou S; Lu D; Ji L; Li Z; Yu S; Meng X
Eur J Med Chem; 2016 Oct; 122():488-496. PubMed ID: 27423028
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of 1-methyl-2-(3',4',5'-trimethoxybenzoyl)-3-aminoindoles as a new class of antimitotic agents and tubulin inhibitors.
Romagnoli R; Baraldi PG; Sarkar T; Carrion MD; Cara CL; Cruz-Lopez O; Preti D; Tabrizi MA; Tolomeo M; Grimaudo S; Di Cristina A; Zonta N; Balzarini J; Brancale A; Hsieh HP; Hamel E
J Med Chem; 2008 Mar; 51(5):1464-8. PubMed ID: 18260616
[TBL] [Abstract][Full Text] [Related]
12. Sea Urchin Embryo Model As a Reliable in Vivo Phenotypic Screen to Characterize Selective Antimitotic Molecules. Comparative evaluation of Combretapyrazoles, -isoxazoles, -1,2,3-triazoles, and -pyrroles as Tubulin-Binding Agents.
Semenova MN; Demchuk DV; Tsyganov DV; Chernysheva NB; Samet AV; Silyanova EA; Kislyi VP; Maksimenko AS; Varakutin AE; Konyushkin LD; Raihstat MM; Kiselyov AS; Semenov VV
ACS Comb Sci; 2018 Dec; 20(12):700-721. PubMed ID: 30452225
[TBL] [Abstract][Full Text] [Related]
13. Simplified pretubulysin derivatives and their biological effects on cancer cells.
Kubisch R; von Gamm M; Braig S; Ullrich A; Burkhart JL; Colling L; Hermann J; Scherer O; Müller R; Werz O; Kazmaier U; Vollmar AM
J Nat Prod; 2014 Mar; 77(3):536-42. PubMed ID: 24437936
[TBL] [Abstract][Full Text] [Related]
14. Quinazolinone-Based Anticancer Agents: Synthesis, Antiproliferative SAR, Antitubulin Activity, and Tubulin Co-crystal Structure.
Dohle W; Jourdan FL; Menchon G; Prota AE; Foster PA; Mannion P; Hamel E; Thomas MP; Kasprzyk PG; Ferrandis E; Steinmetz MO; Leese MP; Potter BVL
J Med Chem; 2018 Feb; 61(3):1031-1044. PubMed ID: 29227648
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and pharmacological evaluation of N-(3-(1H-indol-4-yl)-5-(2-methoxyisonicotinoyl)phenyl)methanesulfonamide (LP-261), a potent antimitotic agent.
Shetty RS; Lee Y; Liu B; Husain A; Joseph RW; Lu Y; Nelson D; Mihelcic J; Chao W; Moffett KK; Schumacher A; Flubacher D; Stojanovic A; Bukhtiyarova M; Williams K; Lee KJ; Ochman AR; Saporito MS; Moore WR; Flynn GA; Dorsey BD; Springman EB; Fujimoto T; Kelly MJ
J Med Chem; 2011 Jan; 54(1):179-200. PubMed ID: 21126027
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationship studies of 3-aroylindoles as potent antimitotic agents.
Liou JP; Mahindroo N; Chang CW; Guo FM; Lee SW; Tan UK; Yeh TK; Kuo CC; Chang YW; Lu PH; Tung YS; Lin KT; Chang JY; Hsieh HP
ChemMedChem; 2006 Oct; 1(10):1106-18. PubMed ID: 16952120
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and antiproliferative activity of the new conjugates of E7010 and resveratrol as tubulin polymerization inhibitors.
Kamal A; Ashraf M; Basha ST; Ali Hussaini SM; Singh S; Vishnuvardhan MV; Kiran B; Sridhar B
Org Biomol Chem; 2016 Jan; 14(4):1382-94. PubMed ID: 26676480
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of resveratrol-based nitrovinylstilbenes as antimitotic agents.
Reddy MA; Jain N; Yada D; Kishore C; Vangala JR; P Surendra R; Addlagatta A; Kalivendi SV; Sreedhar B
J Med Chem; 2011 Oct; 54(19):6751-60. PubMed ID: 21851083
[TBL] [Abstract][Full Text] [Related]
19. A thalidomide analogue with in vitro antiproliferative, antimitotic, and microtubule-stabilizing activities.
Li PK; Pandit B; Sackett DL; Hu Z; Zink J; Zhi J; Freeman D; Robey RW; Werbovetz K; Lewis A; Li C
Mol Cancer Ther; 2006 Feb; 5(2):450-6. PubMed ID: 16505120
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological activities of (R)- and (S)-N-(4-Methoxyphenyl)-N,2,6-trimethyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-aminium chloride as potent cytotoxic antitubulin agents.
Gangjee A; Zhao Y; Hamel E; Westbrook C; Mooberry SL
J Med Chem; 2011 Sep; 54(17):6151-5. PubMed ID: 21786793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
